HCD Fragmentation of Glycated Peptides
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
HCD Fragmentation of Glycated Peptides. / Keilhauer, Eva C; Geyer, Philipp E; Mann, Matthias.
In: Journal of Proteome Research, Vol. 15, No. 8, 05.08.2016, p. 2881-90.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - HCD Fragmentation of Glycated Peptides
AU - Keilhauer, Eva C
AU - Geyer, Philipp E
AU - Mann, Matthias
PY - 2016/8/5
Y1 - 2016/8/5
N2 - Protein glycation is a concentration-dependent nonenzymatic reaction of reducing sugars with amine groups of proteins to form early as well as advanced glycation (end-) products (AGEs). Glycation is a highly disease-relevant modification but is typically only studied on a few blood proteins. To complement our blood proteomics studies in diabetics, we here investigate protein glycation by higher energy collisional dissociation (HCD) fragmentation on Orbitrap mass spectrometers. We established parameters to most efficiently fragment and identify early glycation products on in vitro glycated model proteins. Retaining standard collision energies does not degrade performance if the most dominant neutral loss of H6O3 is included into the database search strategy. Glycation analysis of the entire HeLa proteome revealed an unexpected intracellular preponderance for arginine over lysine modification in early and advanced glycation (end-) products. Single-run analysis from 1 μL of undepleted and unenriched blood plasma identified 101 early glycation sites as well as numerous AGE sites on diverse plasma proteins. We conclude that HCD fragmentation is well-suited for analyzing glycated peptides and that the diabetic status of patients can be directly diagnosed from single-run plasma proteomics measurements.
AB - Protein glycation is a concentration-dependent nonenzymatic reaction of reducing sugars with amine groups of proteins to form early as well as advanced glycation (end-) products (AGEs). Glycation is a highly disease-relevant modification but is typically only studied on a few blood proteins. To complement our blood proteomics studies in diabetics, we here investigate protein glycation by higher energy collisional dissociation (HCD) fragmentation on Orbitrap mass spectrometers. We established parameters to most efficiently fragment and identify early glycation products on in vitro glycated model proteins. Retaining standard collision energies does not degrade performance if the most dominant neutral loss of H6O3 is included into the database search strategy. Glycation analysis of the entire HeLa proteome revealed an unexpected intracellular preponderance for arginine over lysine modification in early and advanced glycation (end-) products. Single-run analysis from 1 μL of undepleted and unenriched blood plasma identified 101 early glycation sites as well as numerous AGE sites on diverse plasma proteins. We conclude that HCD fragmentation is well-suited for analyzing glycated peptides and that the diabetic status of patients can be directly diagnosed from single-run plasma proteomics measurements.
KW - Arginine
KW - Diabetes Mellitus
KW - Glycation End Products, Advanced
KW - Glycopeptides
KW - Glycosylation
KW - HeLa Cells
KW - Humans
KW - Lysine
KW - Mass Spectrometry
KW - Peptide Fragments
KW - Proteome
KW - Proteomics
KW - Journal Article
U2 - 10.1021/acs.jproteome.6b00464
DO - 10.1021/acs.jproteome.6b00464
M3 - Journal article
C2 - 27425404
VL - 15
SP - 2881
EP - 2890
JO - Journal of Proteome Research
JF - Journal of Proteome Research
SN - 1535-3893
IS - 8
ER -
ID: 186875735